Portfoliotracker

Santhera Pharmaceuticals Holding AG

SANN.SW · SWISS · Healthcare Biotechnology 11/100 E

14,24 CHF
▼ −0,18 (−1,25 %)
Trading delayed by 15 min
Price as of 17. 11. 15:21, fetched 17. 11. 15:44
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score11 / 100 Market cap188 mil. CHF P/E– Forward P/E65,5 P/S2,4 P/B– EV/EBITDA– Dividend yield– FCF yield-18,55 % EPS-2,18 CHF Net margin-31,5 % Return on equity– Beta-0,41 Debt / equity–
52-week range 10,12 to 18,84
3-month average volume0,1 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.

Employees
93
Country
Switzerland
Data since
3. 11. 2006

Explore further

Similar companies BSLN.SWNWRN.SWIDIA.SWMOLN.SW

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account